Back to Trades
Total Value
$0
Filing Date
Aug 24, 2026
1 transaction
Trade Summary
On Aug 20, 2026, Astley-Sparke Philip, Director, reported $0 of Replimune Group, Inc. (REPL) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Replimune Group, Inc.
- Ticker Symbol
- REPL
- CIK
- 0001737953
Insider Information
- Role
- Director
- Location
- WOBURN, MA
Filing Details
- Filing Date
- Aug 24, 2026
- Transaction Date
- Aug 20, 2026
- Accession Number
- 0001104659-26-100437
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | 50,000 | — | Bona Fide Gift | — |
Want live alerts when Astley-Sparke Philip trades again?
Download Insider Trades to track REPL, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents a bona fide gift of 50,000 shares from the reporting person to a donor-advised fund.